ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 2094

$1.28M Total Retail Price of All Prescriptions

Rank: 37 out of 2094

806 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 806 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 806 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

3% of this provider’s 13,464 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 653 541 1 4
AMLODIPINE BESYLATE 506 427 2 2
METFORMIN HCL 505 389 3 8
NEXIUM 481 365 4 16
SIMVASTATIN 458 355 5 1
ZOLPIDEM TARTRATE 445 332 6 14
DIOVAN HCT 424 341 7 28
METOPROLOL SUCCINATE 371 283 8 9
GLIMEPIRIDE 333 272 9 31
CRESTOR 288 252 10 15
FUROSEMIDE 261 212 11 6
CLOPIDOGREL 258 214 12 22
DIOVAN 256 230 13 13
ENALAPRIL MALEATE 256 212 13 25
LOSARTAN-HYDROCHLOROTHIAZIDE 255 212 15 52
LOVAZA 247 195 16 53
JANUVIA 241 203 17 35
CLOTRIMAZOLE-BETAMETHASONE 233 189 18 91
LOSARTAN POTASSIUM 232 178 19 17
TAMSULOSIN HCL 220 182 20 29
GLYBURIDE-METFORMIN HCL 213 170 R 21 94
VOLTAREN 195 169 22 109
LEVOTHYROXINE SODIUM 192 177 23 3
ALENDRONATE SODIUM 190 171 24 30
PLAVIX 187 151 25 38
NAPROXEN 185 130 26 84
ATORVASTATIN CALCIUM 177 145 27 5
LISINOPRIL 167 145 28 7
MECLIZINE HCL 152 137 29 103
CARVEDILOL 143 126 30 19
PROAIR HFA 142 100 31 45
IBUPROFEN 136 81 32 73
LANTUS SOLOSTAR 135 99 33 76
METOPROLOL TARTRATE 134 105 34 10
CLONIDINE HCL 132 98 35 62
SINGULAIR 126 90 36 64
CELEBREX 115 94 37 74
HYDROCHLOROTHIAZIDE 111 104 38 12
NAMENDA 111 110 38 32
LANTUS 107 86 40 66
ADVAIR DISKUS 107 69 40 36
ACTOS 107 94 40 112
ATENOLOL 106 78 43 21
WARFARIN SODIUM 102 75 44 11
AVODART 102 99 44 163
JANUMET 101 92 46 86
BENICAR HCT 100 83 47 133
DONEPEZIL HCL 98 96 48 20
MICARDIS HCT 96 53 49 266
EXFORGE 95 88 50 105
MONTELUKAST SODIUM 95 77 50 128
LYRICA 94 79 52 85
GLYBURIDE 91 74 R 53 95
DEXILANT 88 67 54 124
TRAMADOL HCL 87 64 55 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 71 56 55
RANITIDINE HCL 76 69 57 80
LIDODERM 75 62 58 59
OXYCODONE-ACETAMINOPHEN 71 43 S2 59 40
BYSTOLIC 67 64 60 83
ACTOPLUS MET 65 50 61 406
AZITHROMYCIN 63 44 62 27
EVISTA 61 34 63 131
NIFEDIPINE ER 60 47 64 96
EXFORGE HCT 60 56 64 195
LIPITOR 60 42 64 39
VALSARTAN-HYDROCHLOROTHIAZIDE 59 49 67 225
CIPROFLOXACIN HCL 58 44 68 81
DIGOXIN 57 45 69 51
PROCTOZONE-HC 57 42 69 266
ISOSORBIDE MONONITRATE ER 57 53 69 57
MELOXICAM 56 54 72 49
SERTRALINE HCL 55 26 73 26
NABUMETONE 53 36 74 203
FAMOTIDINE 53 51 74 34
METOCLOPRAMIDE HCL 50 37 76 141
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.